RUSSO, Diego
 Distribuzione geografica
Continente #
NA - Nord America 8.448
AS - Asia 5.170
EU - Europa 1.684
SA - Sud America 1.207
Continente sconosciuto - Info sul continente non disponibili 189
AF - Africa 112
OC - Oceania 9
Totale 16.819
Nazione #
US - Stati Uniti d'America 8.141
SG - Singapore 2.403
CN - Cina 1.253
BR - Brasile 930
IT - Italia 727
VN - Vietnam 592
IN - India 476
SE - Svezia 292
GB - Regno Unito 195
CA - Canada 181
DE - Germania 176
AR - Argentina 112
BD - Bangladesh 98
HK - Hong Kong 73
MX - Messico 61
FI - Finlandia 59
EC - Ecuador 57
TR - Turchia 56
ID - Indonesia 42
IQ - Iraq 30
RU - Federazione Russa 30
ZA - Sudafrica 28
ES - Italia 27
UA - Ucraina 27
NL - Olanda 25
CO - Colombia 24
PY - Paraguay 22
PK - Pakistan 20
FR - Francia 19
JP - Giappone 19
IR - Iran 18
PL - Polonia 18
RO - Romania 17
CL - Cile 16
MA - Marocco 16
VE - Venezuela 16
JM - Giamaica 15
DZ - Algeria 13
EE - Estonia 13
UY - Uruguay 12
UZ - Uzbekistan 12
AE - Emirati Arabi Uniti 11
CR - Costa Rica 11
EG - Egitto 11
KE - Kenya 11
PE - Perù 11
DO - Repubblica Dominicana 10
TN - Tunisia 10
IE - Irlanda 9
BE - Belgio 8
ET - Etiopia 8
GR - Grecia 8
SA - Arabia Saudita 8
BO - Bolivia 7
JO - Giordania 7
KR - Corea 7
AU - Australia 6
GT - Guatemala 6
HN - Honduras 6
IL - Israele 6
SV - El Salvador 6
AT - Austria 5
AZ - Azerbaigian 5
CZ - Repubblica Ceca 5
SY - Repubblica araba siriana 5
A2 - ???statistics.table.value.countryCode.A2??? 4
BG - Bulgaria 4
BH - Bahrain 3
DK - Danimarca 3
EU - Europa 3
HR - Croazia 3
KZ - Kazakistan 3
NG - Nigeria 3
NP - Nepal 3
PA - Panama 3
PH - Filippine 3
SC - Seychelles 3
SN - Senegal 3
TT - Trinidad e Tobago 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
CI - Costa d'Avorio 2
KG - Kirghizistan 2
LB - Libano 2
MD - Moldavia 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
TW - Taiwan 2
AG - Antigua e Barbuda 1
AL - Albania 1
BB - Barbados 1
BY - Bielorussia 1
DM - Dominica 1
GN - Guinea 1
HU - Ungheria 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
Totale 16.623
Città #
San Jose 1.490
Chandler 778
Ashburn 746
Dallas 667
Singapore 604
Santa Clara 462
Council Bluffs 387
Hefei 373
Bengaluru 372
Princeton 363
Lawrence 360
Milan 357
Ho Chi Minh City 220
Wilmington 197
Chicago 165
Beijing 164
London 148
Hanoi 121
Munich 120
Ottawa 119
Des Moines 118
São Paulo 77
Los Angeles 70
Hong Kong 69
Phoenix 68
Boardman 66
Shanghai 60
New York 52
Turku 46
Catanzaro 42
Haiphong 38
Norwalk 37
Rio de Janeiro 33
Guangzhou 29
Da Nang 28
Brooklyn 26
Shenzhen 25
Boston 24
Rome 23
Atlanta 22
Redwood City 22
San Francisco 22
Mexico City 21
Pune 21
Chennai 20
Guayaquil 19
Curitiba 18
Quito 18
Thái Bình 18
Hanover 17
Istanbul 17
Montreal 16
Brasília 15
Jiaxing 15
Toronto 15
Washington 15
Belo Horizonte 14
Ninh Bình 14
Porto Alegre 14
Seattle 14
Ankara 13
Campinas 13
Johannesburg 13
Tokyo 13
Biên Hòa 12
Orem 12
Redmond 12
Warsaw 12
Baghdad 11
Buffalo 11
Delhi 11
Helsinki 11
Manaus 11
Salvador 11
Dhaka 10
Horia 10
Hortolândia 10
Jakarta 10
Montevideo 10
Nairobi 10
Newark 10
Stockholm 10
Ann Arbor 9
Florence 9
Fortaleza 9
Houston 9
Hải Dương 9
Kingston 9
Naples 9
Quanzhou 9
San José 9
Tashkent 9
Xi'an 9
Abu Dhabi 8
Bauru 8
Buenos Aires 8
Catania 8
Columbus 8
Guarulhos 8
Nottingham 8
Totale 9.912
Nome #
Biological Activity of Oleuropein and Its Derivatives 188
Liposomes as multicompartmental carriers for multidrug delivery in anticancer chemotherapy 128
Analysis of serum microRNA in exosomal vehicles of papillary thyroid cancer 99
Anti-hTERT siRNA-loaded nanoparticles block the growth of anaplastic thyroid cancer xenograft 96
A case of metastatic medullary thyroid carcinoma: early identification before surgery of a ret proto-oncogene somatic mutation in fine needle aspirate specimen 95
Lipoamino Acid Prodrugs of Paclitaxel: Synthesis and Cytotoxicity Evaluation on Human Anaplastic Thyroid Carcinoma Cells 94
Antiproliferative Effects of Cynaropicrin on Anaplastic Thyroid Cancer Cells 94
Precision oncology for RET-related tumors 92
Hashimoto's thyroiditis and vestibular dysfunction 92
Impact of legumes and plant proteins consumption on cognitive performances in the elderly 90
A large family with hereditary MTC: role of RET genetic analysis in differential diagnosis between MEN 2A and FMTC 89
A novel mutation in the thyrotropin receptor gene causing loss of TSH binding but constitutive receptor activation in a family with resistence to TSH 88
Antiproliferative activity of PDE5 inhibitors vehicled by nanovescicles in thyroid cancer cells. 87
Antiproliferative effects afforded by pyrazolopyrimidine derivates on human neuroblastoma cells 87
IL-20 Subfamily Biological Effects: Mechanistic Insights and Therapeutic Perspectives in Cancer 86
Mediterranean Diet Nutrients to Turn the Tide against Insulin Resistance and Related Diseases 86
Antioxidant and antigrowth action of peracetylated oleuropein in thyroid cancer cells 86
A case of anaplastic Diffuse Large B-Cell Thyroid Lymphoma: unique immunophenotype and unusual clinical presentation 85
A Phe 486 TSH receptor mutation in a autonomously functioning follicular carcinoma that was causing hyperthyroidism 84
A novel mutation in the Thyrotropin receptor gene causing loss of TSH binding but constitutive activation in a family with resistance to TSH 83
A thyroid follicular cancer presenting as a hot nodule and hyperfunctioning because of an activating mutation of the TSH receptor 82
A novel mutation in the thyrotropin (TSH) receptor gene causing loss of TSH binding but constitutive receptor activation in a family with resistance to TSH 82
Anti-hTERT siRNA nanoparticles block the growth of anaplastic thyroid cancer cells in vitro and in vivo. 81
Absence od Sodium/Iodide symporter gene mutations in differentiated human thyroid carcinomas 80
Association between low C-peptide and fragility fractures in postmenopausal women without diabetes 80
Antiproliferative and antioxidant effects of oleuropein and its semisynthetic peracetylated derivatives on breast cancer cells 80
A hyperfunctioning Hurtle cell thyroid carcinoma with a mutation in the thyrotropin receptor 80
A novel de novo germ-line V292M mutation in the extracellular region of RET in a patient with phaeochromocytoma and medullary thyroid carcinoma: Functional characterization 79
A Val 677 activating mutation of the Thyrotropin receptor in a Hürthle cell thyroid carcinoma associated with thyrotoxicosis 79
Activating mutations of the TSH Receptor in differentiated thyroid carcinomas 75
A Val677 activating mutation of the thyrotropin receptor in a Hurtle cell thyroid carcinoma associated with thyrotossicosis 75
A novel de novo germ-line V292M mutation in the extracellular region of RET in a patient with pheochromocytoma and medullary thyroid carcinoma: Functional characterization 75
Expression and cellular localization of Ref-1 in human thyroid carcinoma cell lines 72
A new germline VHL gene mutation in three patients with apparently sporadic pheochromocytoma. 72
Effects of Oleacein on High-Fat Diet-Dependent Steatosis, Weight Gain, and Insulin Resistance in Mice 72
A case of metastatic medullary thyroid carcinoma: Early identification before surgery of an RET proto-oncogene somatic mutation in fine-needle aspirate specimens 72
Adenyl cyclase activity and Gs and Gi alpha ADP-ribosylation in thyroid hyperfunctioning adenomas presenting TSH receptor or Gsp mutations 71
Antiproliferative activity of PDE5 inhibitors vehicled by nanovesicles in thyroid cancer cells 71
Antioxidant and antiproliferative effects of olive-leaf extract oleuropein and its peracetylated derivate on human thyroid cancer cells 71
A call to action: Now is the time to screen elderly and treat osteosarcopenia, a position paper of the italian college of academic nutritionists med/49 (ican-49) 70
A new structural model for the Thyrotropin receptor as determined by covalent crosslinking of Thyrotropin to the recombinant receptor in intact cells: evidence for a single polypeptide chain. 69
TSH-CONJUGATED NANOCARRIER FOR THE TREATMENT OF THYROID CANCER 69
Antiproliferative activity of PDE5 inhibitors vehicle by nanovesicles in thyroid cancer cells. 69
Antiproliferative Effects of Two Pyrazolo-Pyrimidine Derivates on Human Anaplastic Thyroid Cancer Cells 69
Absence of iodide symporter gene mutations in human thyroid tumors 67
A novel germline VHL gene mutation in two different patients with pheochromocytoma. 67
Antiproliferative effects of olive-leaf extract oleuropein and derivatives in human breast cancer cells 67
Identification of Exosomal microRNAs and Their Targets in Papillary Thyroid Cancer Cells 66
Vestibular disorders in euthyroid patients with Hashimoto’s thyroiditis: role of thyroid autoimmunity. 65
Evaluation of biological effects of TERT inhibition in human thyroid cancer cells 64
Epigenetic-related gene expression profile in Medullary Thyroid Cancer revealed the overexpression of the Histone methyltransferases EZH2 and SMYD3 in aggressive tumours. 64
Analisi della proteina APE/Ref-1 nei noduli tiroidei iperfunzionanti: aumento dell’espressione nelle frazioni nucleari 64
Detection of an activating mutation of the TSH receptor in a case of an autonomously hyperfunctioning thyroid insular carcinoma 64
Co-Encapsulation of Paclitaxel and JQ1 in Zein Nanoparticles as Potential Innovative Nanomedicine 63
Carcinomi differenziati della tiroide: ruolo oncogenico del recettore del TSH 63
APE/Ref-1 is increased in nuclear fractions of human thyroid hyperfunctioning nodules 63
Gemcitabine-loaded PEGylated unilamellar liposomes vs GEMZAR®: Biodistribution, pharmacokinetic features and in vivo antitumor activity 63
Ape1/Ref-1 is increased in nuclear fractions of human thyroid hot nodules 62
Prohibitin is overexpressed in papillary thyroid carcinomas bearing the BRAFV600E mutation 61
MicroRNAs as Biomarkers in Thyroid Carcinoma 61
Dihydrotanshinone exerts antitumor effects and improves the effects of cisplatin in anaplastic thyroid cancer cells 61
The cyclic AMP response element binding protein (CREB) is functionally reduced in human toxic thyroid adenomas 59
Expression and localization of the sodium/iodide symporter (NIS) in testicular cells 59
A Val677 activating mutation of the thyrotropin receptor in a Hürtle cell thyroid carcinoma associated with thyrotoxicosis 59
High periostin expression correlates with aggressiveness in papillary thyroid carcinomas 59
Carcinoma midollare della tiroide: identificazione di una nuova mutazione 59
Expression of YAP1 in aggressive thyroid cancer 59
Functional interaction among thyroid specific transcription factors: PAX8 regulates the activity of Hex promoter 58
Normocaloric Diet Restores Weight Gain and Insulin Sensitivity in Obese Mice 58
Maggisano V., Capriglione F., Mio C., Bulotta S., Damante G., Russo D., Celano M 57
Functional analysis of the cytoplasmic domains of the human TSH receptor by site-directed mutagenesis. 57
NANOVETTORE CONIUGATO CON TSH PER IL TRATTAMENTO DEL CANCRO DELLA TIROIDE 57
Alterazioni del trasportatore dello iodio in patologia tiroidea 56
A synonymous RET substitution enhances the oncogenic effect of an in-cis missense mutation by increasing constitutive splicing efficiency. 56
Genetic analysis in fine needle aspiration of the thyroid: a new tool for clinic 56
An activating mutation in the thyrotropin receptor causing thyrotoxicosis in a Hurtle cell thyroid carcinoma 56
Expression of adenylyl cyclase types III and VI in human hyperfunctioning thyroid nodules 56
B-RAF mutations in papillary thyroid carcinomas inhibit genes involved in iodine metabolism 56
Whole exome sequencing identifies a germline MET mutation in two siblings with hereditary wild-type RET medullary thyroid cancer. 56
Oleacein inhibits STAT3, activates the apoptotic machinery, and exerts anti-metastatic effects in the SH-SY5Y human neuroblastoma cells 56
Safety Evaluation of Subchronic Oral Administration of Oleuropein and its Semisynthetic Peracetylated Derivative 56
Evaluation of somatic genomic imbalances in thyroid carcinomas of follicular origin by CGH-based approaches. 55
Regulation by Insulin, IGF-I, IGF-II and Prolactin of iodide uptake and sodium/iodide symporter expression in the MCF-7 human breast cancer cell line 55
BRAF V600E mutation and expression of proangiogenic molecular markers in papillary thyroid carcinomas 55
APE/Ref-1 is increased in nuclear fractions of human thyroid hyperfuctioning nodules 55
Secretome Analysis of Hypoxia-Induced 3T3-L1 Adipocytes Uncovers Novel Proteins Potentially Involved in Obesity 55
Targeting the thyroid gland with thyroid-stimulating hormone (TSH)-nanoliposomes. 55
Expression of miR-31-5p affects growth, migration and invasiveness of papillary thyroid cancer cells 54
Control of PTEN gene expression in normal and neoplastic thyroid cells 54
Identification of thyroid-associated serum microrna profiles and their potential use in thyroid cancer follow-up 54
Genetica molecolare delle tireopatie 54
A Phe 486 thyrotropin receptor mutation in an autonomously functioning follicular carcinoma that was causing hyperthyroidism 54
Growth inhibition of medullary thyroid carcinoma cells by pyrazolo-pyrimidine derivate 53
Gemcitabine-loaded biocompatible nanocapsules for the effective treatment of human cancer 53
Eleven amino acids (Lys-201 to Lys-211) and 9 amino acids (Gly-222 to Leu-230) in the human thyrotropin receptor are involved in ligand binding. 53
Aqueous–core PEG-coated PLA nanocapsules for an efficient entrapment of water soluble anticancer drugs and a smart therapeutic response 53
Analysis of YAP1 expression in papillary thyroid cancer, lymph node metastases and medullary thyroid cancer. 53
PDE5 expression in human thyroid tumors and effects of PDE5 inhibitors on growth and migration of cancer cells 53
Iodide symporter gene expression in normal and transformed rat thyroid cells 53
hNIS protein in thyroid: the iodine supply influences its expression and localization 52
Totale 6.977
Categoria #
all - tutte 178.973
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 178.973


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022859 0 0 0 185 117 11 37 210 80 59 147 13
2022/20232.398 738 98 73 186 246 204 5 174 351 135 146 42
2023/2024834 164 142 57 43 49 229 13 36 16 17 12 56
2024/20253.321 551 316 155 180 123 415 24 87 450 286 227 507
2025/20267.372 243 925 961 1.549 686 222 837 503 830 377 157 82
2026/20271.483 76 419 735 253 0 0 0 0 0 0 0 0
Totale 16.819